Civil Litigation
Sep. 13, 2017
Plaintiff attacks defense’s science in coffee-cancer link trial
Attorneys for a nonprofit at trial with Starbucks Corp. and retailers over whether they failed to warn of a carcinogen in coffee are aiming at the defense’s underlying science in hopes of unraveling its case.
LOS ANGELES — Attorneys for a nonprofit at trial against Starbucks Corp. and other retailers over whether they failed to warn of a carcinogen in coffee are aiming at the defense’s underlying science in hopes of unraveling its case.
The Council on Education and Research on Toxics said the presence in coffee of acrylamide, a chemical associated with the development of cancer in animals, violates the state’s Safe Drinking Water and Toxic Enforcement Act. Pursuant to Proposition 65, passed...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In